LATEST HEALTH NEWS
In women with uterine carcinosarcomas, paclitaxel plus carboplatin (PC) combination was linked to longer progression-free survival (PFS) outcomes when compared with paclitaxel plus ifosfamide (PI), stated clinical trial.
from Medindia Health News http://bit.ly/2QH4J9P
No comments
Thanks for comment via will connect you within 24 hours.